Cancer Research Annual Meeting 2010 Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miller, D. C.
Right arrow Articles by Cooney, K. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miller, D. C.
Right arrow Articles by Cooney, K. A.
[Cancer Research 63, 3486-3489, July 1, 2003]
© 2003 American Association for Cancer Research

Advances in Brief

Germ-line Mutations of the Macrophage Scavenger Receptor 1 Gene

Association with Prostate Cancer Risk in African-American Men1

David C. Miller, S. Lilly Zheng, Rodney L. Dunn, Aruna V. Sarma, James E. Montie, Ethan M. Lange, Deborah A. Meyers, Jianfeng Xu and Kathleen A. Cooney2

Departments of Urology [D. C. M., R. L. D., A. V. S., J. E. M., K. A. C.] and Internal Medicine [K. A. C.], University of Michigan, Medical School, Ann Arbor, Michigan 48109-0946, and Department of Public Health Sciences and Center for Human Genetics, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157-1063 [S. L. Z., E. M. L., D. A. M., J. X.]

Both rare germ-line mutations and common sequence variants of the macrophage scavenger receptor 1 (MSR1) gene have recently been implicated as potential prostate cancer susceptibility factors. However, existing studies are limited by the referral-based nature of samples and a paucity of African-American participants. In this context, we evaluated the association of germ-line mutations and common MSR1 sequence variants with prostate cancer risk in a case control study of a community-based sample of 134 African-American men with prostate cancer and 340 unaffected controls. In our sample, the rare Asp174Tyr missense change was identified nearly twice as frequently in men with prostate cancer (6.8%) compared with unaffected controls (3.6%; P = 0.14). Moreover, significantly different allele frequencies between cases and controls were observed for one of the sequence variants, IVS5–59 (P = 0.02). Taken together, our results provide some additional support for the hypothesis that selected, rare MSR1 mutations are associated with increased prostate cancer susceptibility among African-American men.




This article has been cited by other articles:


Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
Y.-C. Chen, E. Giovannucci, P. Kraft, and D. J. Hunter
Association between Genetic Polymorphisms of Macrophage Scavenger Receptor 1 Gene and Risk of Prostate Cancer in the Health Professionals Follow-up Study
Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 1001 - 1003.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
A. W. Hsing, L. C. Sakoda, J. Chen, A. P. Chokkalingam, I. Sesterhenn, Y.-T. Gao, J. Xu, and S.L. Zheng
MSR1 variants and the risks of prostate cancer and benign prostatic hyperplasia: a population-based study in China
Carcinogenesis, December 1, 2007; 28(12): 2530 - 2536.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
X. Liu, F. R. Schumacher, S. J. Plummer, E. Jorgenson, G. Casey, and J. S. Witte
trans-Fatty acid intake and increased risk of advanced prostate cancer: modification by RNASEL R462Q variant
Carcinogenesis, June 1, 2007; 28(6): 1232 - 1236.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
R A Kittles, A B Baffoe-Bonnie, T Y Moses, C M Robbins, C Ahaghotu, P Huusko, C Pettaway, S Vijayakumar, J Bennett, G Hoke, et al.
A common nonsense mutation in EphB2 is associated with prostate cancer risk in African American men with a positive family history
J. Med. Genet., June 1, 2006; 43(6): 507 - 511.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
H. Rennert, C. M. Zeigler-Johnson, K. Addya, M. J. Finley, A. H. Walker, E. Spangler, D. G.B. Leonard, A. Wein, S. B. Malkowicz, and T. R. Rebbeck
Association of Susceptibility Alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with Prostate Cancer Severity in European American and African American Men
Cancer Epidemiol. Biomarkers Prev., April 1, 2005; 14(4): 949 - 957.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
Q. Hope, S. Bullock, C. Evans, J. Meitz, N. Hamel, S. M. Edwards, G. Severi, D. Dearnaley, S. Jhavar, C. Southgate, et al.
Macrophage Scavenger Receptor 1 999C>T (R293X) Mutation and Risk of Prostate Cancer
Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 397 - 402.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
D. M. Friedrichsen, J. L. Stanford, S. D. Isaacs, M. Janer, B.-l. Chang, K. Deutsch, E. Gillanders, S. Kolb, K. E. Wiley, M. D. Badzioch, et al.
Identification of a prostate cancer susceptibility locus on chromosome 7q11-21 in Jewish families
PNAS, February 17, 2004; 101(7): 1939 - 1944.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.